$19.16
-0.18-0.93%
Last update: Oct 23, 4:00 PM
Beta Bionics Inc (BBNX) Stock Price, Quote, News & History
BBNXNASDAQ
The FDA authorized Abbott's Libre Duo 10 Day, the first wearable tracking both glucose and ketones continuously for diabetes patients.
You can purchase shares of Beta Bionics (NASDAQ:BBNX) through any online brokerage.
Other companies in Beta Bionics’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Beta Bionics has a consensus price target of $25.31.
The stock price for Beta Bionics (NASDAQ: BBNX) is $19.16 last updated October 23, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Beta Bionics.
Beta Bionics does not have any upcoming earnings scheduled.
There is no upcoming split for Beta Bionics.
Beta Bionics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive...
